Vioxx Plaintiff Wants Merck's Dose, Naproxen Testimony Excluded

ANGLETON, Texas - Testimony from several Merck experts who say there is no data supporting the claim that Vioxx causes sudden cardiac death should be stricken because it runs contrary to relevant epidemiological evidence supporting the link, plaintiffs in a Texas Vioxx case argue in a motion filed recently. Ernst v. Merck & Co. Inc., et al., No. 19961*BH02 (Texas Dist. Ct., Brazoria Cty.).

According to a series of motions filed June 29, several of Merck's experts ignore the established clinical evidence indicating a more than two-fold risk of serious coronary heart disease, including sudden cardiac death, among users of …